DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
18.55
+0.06 (0.32%)
May 8, 2026, 3:00 PM CST

SHA:603233 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,05720,06617,15128,35937,58533,307
Market Cap Growth
10.78%17.00%-39.52%-24.55%12.85%-35.46%
Enterprise Value
20,42520,65720,00631,25140,04435,732
Last Close Price
18.4917.6214.4923.0129.9226.12
PE Ratio
16.3916.2518.7524.3136.2942.10
Forward PE
15.4016.9716.4423.7631.3728.06
PS Ratio
0.770.730.651.161.771.99
PB Ratio
2.292.322.113.585.485.61
P/TBV Ratio
8.6010.3812.2014.6111.7111.90
P/FCF Ratio
5.224.1210.5220.5913.81128.08
P/OCF Ratio
4.633.755.528.9410.0121.42
PEG Ratio
0.910.450.451.131.451.44
EV/Sales Ratio
0.740.750.761.271.892.13
EV/EBITDA Ratio
9.378.666.399.6322.1527.36
EV/EBIT Ratio
9.579.8612.9317.4025.1832.45
EV/FCF Ratio
5.064.2512.2722.6914.71137.41
Debt / Equity Ratio
0.560.640.950.820.860.89
Debt / EBITDA Ratio
2.372.232.472.012.062.34
Debt / FCF Ratio
1.281.134.754.732.1820.29
Net Debt / Equity Ratio
-0.21-0.170.190.260.200.40
Net Debt / EBITDA Ratio
-0.93-0.610.480.630.741.82
Net Debt / FCF Ratio
-0.48-0.300.921.490.509.13
Asset Turnover
1.031.041.051.091.111.13
Inventory Turnover
4.264.374.193.923.533.29
Quick Ratio
0.590.570.580.540.620.55
Current Ratio
0.930.890.920.941.101.10
Return on Equity (ROE)
15.77%16.18%12.20%16.63%16.86%13.98%
Return on Assets (ROA)
4.98%4.95%3.83%4.99%5.21%4.64%
Return on Invested Capital (ROIC)
21.76%18.27%11.54%14.93%14.69%15.65%
Return on Capital Employed (ROCE)
18.00%18.30%12.20%14.20%14.30%10.80%
Earnings Yield
6.11%6.16%5.33%4.11%2.76%2.38%
FCF Yield
19.17%24.25%9.51%4.86%7.24%0.78%
Dividend Yield
3.64%-4.28%1.35%1.67%1.33%
Payout Ratio
60.51%63.31%82.34%51.82%40.58%67.53%
Buyback Yield / Dilution
-0.71%-1.28%0.28%0.50%-0.69%0.24%
Total Shareholder Return
2.94%-1.28%4.56%1.84%0.98%1.57%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.